A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1994
12/28/1994	EP0630243A1 Combinations of parasympathomimetic agents with muscarinic antagonists for treating nicotine craving in smoking cessation
12/28/1994	EP0630240A1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists
12/28/1994	EP0617705A4 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them.
12/28/1994	EP0346429B1 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)
12/28/1994	CN1096787A Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
12/28/1994	CN1096783A Salt of derivative of 4-pyrimidone and preparation and medical application of same
12/28/1994	CN1027136C Wound healing
12/28/1994	CN1027134C Method for preparation of joint lubricant for use as physiological lubricant
12/27/1994	US5376680 Oxime derivatives
12/27/1994	US5376669 Antitumor agents
12/27/1994	US5376668 Cholinergic agents as cognition activators in treatment of Alzheimer*s disease
12/27/1994	US5376653 A protease enzyme inhibitor for treating degenerative diseases , respiratory system disorders, rheumatoid arthritis and pancreatitis
12/27/1994	US5376647 bisphosphonic acid derivatives, and useful as a bone resorption inhibitor
12/27/1994	US5376638 Methods for treating renin-related disorders with amylin antagonists
12/27/1994	US5376636 Method for promoting tissue repair and regeneration using PDGF and glucocorticoids
12/27/1994	US5376384 Delayed, sustained-release pharmaceutical preparation
12/27/1994	US5376371 Topical; extracts from Salvia and Ginkgo leaves with excipient ; adenylate cyclase agonist and phosphodiesterase inhibitor
12/27/1994	US5375693 Methods and compositions for treating allergic disorders and other disorders metabolic derivatives of terfenadine
12/27/1994	CA1333714C Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis
12/22/1994	WO1994029462A1 Multicistronic expression of recombinant genes in bacterial cells
12/22/1994	WO1994029449A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
12/22/1994	WO1994029448A1 Dna and protein coded for thereby
12/22/1994	WO1994029341A1 Methods of enhancing bioactivity of chemokines
12/22/1994	WO1994029336A1 New peptide derivatives
12/22/1994	WO1994029299A1 Imidazole lipoxygenase inhibitors
12/22/1994	WO1994029297A1 2-oxo-1,2,3,4-tetrahydroquinoline derivatives
12/22/1994	WO1994029291A1 Aniline derivatives
12/22/1994	WO1994029290A1 Secondary amines as antidiabetic and antiobesity agents
12/22/1994	WO1994029286A1 Analgesic dibenzoxazepines and dibenzothiazepines
12/22/1994	WO1994029280A1 Pyrimidine cyanoguanidines as k-channel blockers
12/22/1994	WO1994029262A1 Lipoxin compounds
12/22/1994	WO1994029255A1 Aromatic acetylcholinesterase inhibitors
12/22/1994	WO1994028916A1 Release and mobilisation of haematopoietic cells
12/22/1994	WO1994028914A1 Assay and reagents for identifying anti-proliferative agents
12/22/1994	WO1994028900A1 Methods and compositions for lowering intraocular pressure
12/22/1994	WO1994028897A2 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
12/22/1994	WO1994028895A2 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
12/22/1994	WO1994028886A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease
12/22/1994	WO1994028880A1 Extended release, film-coated tablet of astemizole and pseudoephedrine
12/22/1994	WO1994028721A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	WO1994022835A3 Heterocyclic compounds as platelet aggregation inhibitors
12/22/1994	WO1994022483A3 Prodrugs with enhanced penetration into cells
12/22/1994	CA2165159A1 Analgesic dibenzoxazepines and dibenzothiazepines
12/22/1994	CA2164733A1 Methods and compositions for lowering intraocular pressure
12/22/1994	CA2164641A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
12/22/1994	CA2164632A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	CA2164317A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease
12/22/1994	CA2164009A1 Secondary amines as antidiabetic and antiobesity agents
12/22/1994	CA2163121A1 Extended release, film-coated tablet of astemizole and pseudoephedrine
12/22/1994	CA2161811A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
12/22/1994	CA2161325A1 Pyrimidine, cyanoguandines as k-channel blockers
12/22/1994	CA2140660A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
12/21/1994	EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them
12/21/1994	EP0629627A2 Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors
12/21/1994	EP0629617A1 Heteroatom-bearing ligands and metal complexes thereof
12/21/1994	EP0629409A1 Tetrapyrrole carboxylic acid derivatives for diagnosis and/or therapy of arthritis
12/21/1994	EP0629405A1 Agent for inhibiting a decrease in bone mass in renal osteodystrophy
12/21/1994	EP0629401A1 Use of 1,2,4-dithiazolium salts as chemotherapeutics, particularly as TNF-inhibitors, and now 1,2,4-dithiazolium salts
12/21/1994	EP0629211A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation
12/21/1994	EP0629199A1 Indole derivatives as 5-ht1 agonists
12/21/1994	EP0629198A1 Nitrogen containing heterocyclic compounds useful as pharmaceuticals
12/21/1994	EP0629196A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them
12/21/1994	EP0610368A4 Treatment of acne or of pseudofolliculitis barbae.
12/21/1994	CN1096513A Endothelin receptor antagonists
12/21/1994	CN1027068C Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acide and-esters
12/20/1994	US5374772 Substituted benzoic acids, inhibitors of phospholipases A2
12/20/1994	US5374710 Compounds which release nitric oxide upon illumination
12/20/1994	US5374652 Substituted naphthylmethylene- or tetrahydronaphthylmethylene-derivatives of 2-oxoindole
12/20/1994	US5374649 Indole derivatives and pharmaceutical use thereof
12/20/1994	US5374648 Nervous system disorders
12/20/1994	US5374640 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
12/20/1994	US5374635 Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis
12/20/1994	US5374629 Vitamin D analogues
12/20/1994	US5374623 Cysteine protease inhibitors effective for in vivo use
12/20/1994	US5374618 Calcitonin peptides, and gene related pharmaceutical compositions
12/20/1994	US5374550 Thyroid-derived chondrocyte-stimulating factor
12/20/1994	US5374431 Polypeptide chains having helical structure in aqueous environments containing crosslinkable surface adherable amino acids; form insoluble matrix for adhering cells
12/20/1994	EP0650366A4 Compositions and methods for treating wounds.
12/20/1994	CA1333647C Heptapeptide analogs of somatostatin
12/20/1994	CA1333570C Topically applicable preparations for treatment of presbyderma
12/18/1994	CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them
12/15/1994	CA2125725A1 Urea derivative containing heterocyclic ring
12/15/1994	CA2124912A1 Therapeutic composition
12/14/1994	EP0628569A1 Triterpene derivatives and endothelin-receptor antagonists containing the same
12/14/1994	EP0628557A1 Biphenylmethane derivatives, the use of them and pharmacological compositions containing same
12/14/1994	EP0628556A1 Imidazopyridines
12/14/1994	EP0628551A1 Semicyclic urea derivatives as antihistaminic agents
12/14/1994	EP0628550A2 Pyridazines as interleukin-1beta converting enzyme inhibitors
12/14/1994	EP0628543A1 Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them
12/14/1994	EP0628307A2 Methods for administering biological agents and microparticle compositions useful in these and other methods
12/14/1994	EP0628046A1 Triazolopyrimidin derivatives as antiotensin ii receptor antagonists
12/14/1994	EP0628045A1 Pyrazolopyrimidin derivatives as angiotensin ii receptor antagonists
12/14/1994	EP0628042A1 Serotoninergic ergoline derivatives
12/14/1994	EP0628041A1 Heterocyclic compounds and their preparation and use
12/14/1994	EP0628038A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION
12/14/1994	EP0628036A1 N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea compounds having lipoxygenase inhibitory activity
12/14/1994	EP0628033A1 Benzodiazepin derivatives useful as cck-receptor antagonists
12/14/1994	EP0627921A1 Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof
12/14/1994	EP0627917A1 Cytoprotective compositions containing pyruvate and antioxidants
12/14/1994	EP0573522B1 1-azabicyclo[3.2.2]nonan-3-amine derivatives

1 ... 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 ... 1564